May 17, 2020

Amgen Inc to boost dividend 31% for first quarter of 2013

world's largest biotechnology company
first biotechnol
1 min
Amgen Inc to hike dividend 31% for first quarter of 2013
Amgen Inc said it will raise its dividend 31% for the first quarter of next year and buy back the additional $2 billion in shares. The worlds largest b...

Amgen Inc said it will raise its dividend 31% for the first quarter of next year and buy back the additional $2 billion in shares. The world’s largest biotechnology company will pay stockholders 47 cents on March 7, the Thousand Oaks, said.

Amgen became the first biotechnology company to pay a dividend in July 2011. The current payment is 36 cents and the analyst estimated a rise to 40 cents.

The biotechnology firm is looking for new products and buyouts to up revenue as its earlier core anemia business fell. On Dec 10, the company had agreed to acquire DeCode Genetcs Inc, a genetics research company, for $415 million.

Besides, earlier this year, Amgen bought Micromet Inc for $1.16 billion to add an experimental leukemia drug. It also signed a development deal with London-based AstraZeneca Plc and also boosted its presence in the cancer market through sales of Xgeva, a bone drug that reduces fractures.

The company also said it has authorized further share repurchase with $500 million left to spend from its present $10 billion program.

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. It was the first company to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant to patient. 

Share article

Jun 17, 2021

Dexcom: changing the lives of people with type 1 diabetes

3 min
British actress Nina Wadia OBE tells us how her son's life has changed since using glucose monitoring system Dexcom

It is estimated that 9.3% of adults around the world are living with type 1 diabetes, which amounts to a total of 463 million people. A further 1.1 million children and adolescents under the age of 20 are living with the condition. 

Unlike the more prevalent type 2 diabetes, where the body still produces insulin and symptoms develop slowly, people with type 1 diabetes need regular insulin injections or pumps, and must monitor their sugar levels frequently. 

In recent years a number of remote glucose monitoring systems have become available that patients can use at home. These work with a sensor, usually placed under the skin, that measures glucose levels every few minutes. This information is then transmitted wirelessly to a device like a smartphone or tablet, which can then be shared with their clinician. 

British actress Nina Wadia's son Aidan, 14, has type 1 diabetes, and has been managing his condition using Dexcom, a glucose monitoring system used by patients all over the world. Here Wadia explains how Dexcom has improved their lives. 

As a parent of someone with type 1 diabetes, what is your day-to-day life like?
Being able to take a breath, think and pivot constantly without getting frustrated becomes an essential mindset because sometimes it feels like each day is determined to be different from the day before. Whatever worked yesterday is going to misfire today. 

Which areas of yours and Aidan’s life are most impacted by diabetes? 
The one thing that you have to fight hard to reclaim is spontaneity, especially when it comes to food and exercise. It’s only when this is taken do you realise how essential each one is. You can be flexible and there are no real limits, but only in the sense that a great athlete can be flexible without limits because they’ve trained super hard to be that way. So we’ve all had to become athletes when it comes to being spontaneous.

How has Dexcom helped you and Aidan? 
Dexcom has brought future science fiction to real life today. The continuous glucose monitoring system is tiny, sits discreetly on his body and gives him a ten-day breather between sensor changes, so it's goodbye finger-pricking seven times daily. 

Dexcom is totally active at a grass roots level and for Diabetes Awareness has pledged to donate £2,000 if #DexcomDiabetesStories and/or #DexcomWarriorStories is shared 200 times! I’ll be sharing more on social media and would love to hear how other families are winning their fights.

Maybe most importantly Dexcom is trying to introduce a reimbursement programme for type 1 diabetes  patients which will give greater access to modern, life changing hi-tech. I want to spread the word on the importance of accessing it through this campaign. 

If you compared your life today with how it was before Aidan was using Dexcom, what has changed? 
It's always working, which lets him take his mind off diabetes for longer stretches. It also lets me get off his back. We both receive alerts so I no longer have to pester him by asking him what his number is, and especially importantly, I don’t have to wake him at night to prick his finger if I’m worried. Dexcom gave us back our sleep!

Share article